Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · see citing works

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119 · see citing works

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616 · see citing works

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Johansson, M. A., Quandelacy, T. M., Kada, S., Prasad, P. V., Steele, M. K., Brooks, J. T., Slayton, R. B., Biggerstaff, M., & Butler, J. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.35057 · Cited by 1,028 · see citing works

Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing

Rodino, K. G., Espy, M. J., Buckwalter, S. P., Walchak, R. C., Germer, J. J., Fernholz, E. C., Boerger, A. C., Schuetz, A. N., Yao, J. D. C., & Binnicker, M. J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00590-20 · Cited by 107 · see citing works

Postvaccination COVID-19 among Healthcare Workers, Israel

Amit, S., Beni, S., Biber, A., Grinberg, A., Leshem, E., & Regev‐Yochay, G. (2021) · Emerging infectious diseases · doi:10.3201/eid2704.210016 · Cited by 102 · see citing works

Deployment of an Interdisciplinary Predictive Analytics Task Force to Inform Hospital Operational Decision-Making During the COVID-19 Pandemic

Amrami, K. K., Domnick, R., Heinzen, E. P., Helfinstine, K., Jayakumar, A., Johnson, P. W., Knepper, C., Marcelletti, D., Mickelson, M. M., Rojas, R. L., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.12.019 · Cited by 19 · see citing works

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Voysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B. J., Baillie, V., Barnabas, S. L., Bhorat, Q. E., et al. (2022) · Apollo (University of Cambridge) · doi:10.17863/cam.87862 · Cited by 15 · see citing works

Revamping Outpatient Care for Patients Without COVID-19

Storino, C. B., Watson, J. C., Sánchez, W., Brown, M. J., Tande, A. J., & Loftus, C. G. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.010 · Cited by 11 · see citing works

Low Utility of Repeat Real-Time PCR Testing for SARS-CoV-2 in Clinical Specimens

Challener, D. W., Shah, A., O’Horo, J. C., Berbari, E. F., Binnicker, M. J., & Tande, A. J. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.020 · Cited by 11 · see citing works

Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic

Shah, A., Tande, A. J., Challener, D. W., O’Horo, J. C., Binnicker, M. J., & Berbari, E. F. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.039 · Cited by 8 · see citing works

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

Thomas, S. J., Moreira, E. D., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Polack, F. P., Zerbini, C., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110345 · Cited by 1,640 · see citing works

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review

Fiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.005 · Cited by 911 · see citing works

Safety, immunogenicity, and efficacy of the BNT162b2 covid-19 vaccine in adolescents

Frenck, R. W., Klein, N. P., Kitchin, N., Gurtman, A., Absalon, J., Lockhart, S., Perez, J. L., Walter, E. B., Senders, S., Bailey, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107456 · Cited by 889 · see citing works

Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis

Zheng, C., Shao, W., Chen, X., Zhang, B., Wang, G., & Zhang, W. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.11.009 · Cited by 686 · see citing works

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., Campbell, T. B., Clark, J., Jackson, L. A., Fichtenbaum, C. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2113017 · Cited by 641 · see citing works

Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Sadarangani, M., Marchant, A., & Kollmann, T. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00578-z · Cited by 560 · see citing works

COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021

CDC COVID-19 Vaccine Breakthrough Case Investigations Team, CDC COVID-19 Vaccine Breakthrough Case Investigations Team, Birhane, M., Bressler, S., Chang, G., Clark, T., Dorough, L., Fischer, M., Watkins, L. F., Goldstein, J. M., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7021e3 · Cited by 421 · see citing works

The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review

Mohammed, I., Nauman, A., Paul, P., Ganesan, S., Chen, K.-H., Jalil, S. M. S., Jaouni, S. H., Kawas, H., Khan, W. A., Vattoth, A. L., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2027160 · Cited by 406 · see citing works

Accelerated COVID-19 vaccine development: milestones, lessons, and prospects

Bok, K., Sitar, S., Graham, B. S., & Mascola, J. R. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.017 · Cited by 254 · see citing works

The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis

Rahmani, K., Shavaleh, R., Forouhi, M., Disfani, H. F., Kamandi, M., Oskooi, R. K., Foogerdi, M., Soltani, M., Rahchamani, M., Mohaddespour, M., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.873596 · Cited by 207 · see citing works

Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020)

Hanson, K. E., Caliendo, A. M., Arias, C. A. D., Englund, J. A., Hayden, M. K., Lee, M. J., Loeb, M. B., Patel, R., Altayar, O., Alayli, A. E., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1343 · Cited by 179 · see citing works

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19

Struyf, T., Deeks, J. J., Dinnes, J., Takwoingi, Y., Davenport, C. F., Leeflang, M., Spijker, R., Hooft, L., Emperador, D., Domen, J., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013665.pub3 · Cited by 174 · see citing works

Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2

Dangi, T., Class, J., Palacio, N. M., Richner, J. M., & Penaloza‐MacMaster, P. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109664 · Cited by 145 · see citing works

COVID‐19 vaccinations: The unknowns, challenges, and hopes

Mohamed, K., Rzymski, P., Islam, M. S., Makuku, R., Mushtaq, A., Khan, A., Ivanovska, M., Makka, S. A., Hashem, F., Marquez, L. P., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27487 · Cited by 142 · see citing works

A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease

Higdon, M. M., Wahl, B., Jones, C. B., Rosen, J. G., Truelove, S., Baidya, A., Nande, A., ShamaeiZadeh, P. A., Walter, K. K., Feikin, D. R., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac138 · Cited by 125 · see citing works

Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021

Harder, T., Koch, J., Vygen-Bonnet, S., Külper‐Schiek, W., Pilic, A., Reda, S. A., Scholz, S. M., & Wichmann, O. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.28.2100563 · Cited by 120 · see citing works

Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody

Dangi, T., Sanchez, S., Class, J., Richner, M., Visvabharathy, L., Chung, Y. R., Bentley, K., Stanton, R. J., Koralnik, I. J., Richner, J. M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci162282 · Cited by 69 · see citing works

Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021

Mazagatos, C., Monge, S., Olmedo, C., Vega‐Piris, L., Gallego, P., Martín‐Merino, E., Sierra, M. J., Limia, A., Larrauri, A., & Working Group for the surveillance and control of COVID-19 in Spain (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.24.2100452 · Cited by 74 · see citing works

Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study

Layan, M., Gilboa, M., Gonen, T., Goldenfeld, M., Meltzer, L., Andronico, A., Hozé, N., Cauchemez, S., & Regev‐Yochay, G. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac042 · Cited by 67 · see citing works

Brief review of the mRNA vaccines COVID-19

Vitiello, A., & Ferrara, F. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00811-0 · Cited by 64 · see citing works

Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Incidence of the Presumptive B.1.427/B.1.429 Variant Among Healthcare Personnel at a Northern California Academic Medical Center

Jacobson, K. B., Pinsky, B. A., Montez Rath, M. E., Wang, H., Miller, J. A., Skhiri, M., Shepard, J., Mathew, R., Lee, G., Bohman, B., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab554 · Cited by 62 · see citing works

The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (June 2021)

Hanson, K. E., Altayar, O., Caliendo, A. M., Arias, C. A. D., Englund, J. A., Hayden, M. K., Lee, M. J., Loeb, M. B., Patel, R., Alayli, A. E., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab557 · Cited by 55 · see citing works

A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures

Kiem, C. T., Massonnaud, C., Lévy-Bruhl, D., Poletto, C., Colizza, V., Bosetti, P., Fontanet, A. L., Gabet, A., Olié, V., Zanetti, L. C. D. S., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101001 · Cited by 51 · see citing works

Digital Health Passes in the Age of COVID-19

Gostin, L. O., Cohen, I. G., & Shaw, J. (2021) · JAMA · doi:10.1001/jama.2021.5283 · Cited by 51 · see citing works

Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and ReportsPreprint

Shapiro, J., Dean, N. E., Madewell, Z. J., Yang, Y., Halloran, M. E., & Longini, I. M. (2021) · medRxiv · doi:10.1101/2021.05.20.21257461 · Cited by 46 · see citing works

Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)

Varley, C. D., & Winthrop, K. L. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-01037-3 · Cited by 47 · see citing works

Persistent SARS‐CoV‐2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection

Arostegui, D., Castro, K., Schwarz, S. M., Vaidy, K., Rabinowitz, S. S., & Wallach, T. E. (2021) · JPGN Reports · doi:10.1097/pg9.0000000000000152 · Cited by 47 · see citing works

Indirect Protection by Reducing Transmission: Ending the Pandemic With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination

Richterman, A. G., Meyerowitz, E. A., & Çevik, M. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab259 · Cited by 44 · see citing works

SARS-CoV-2 Vaccines: Where Are We Now?

Flanagan, K. L., MacIntyre, C. R., McIntyre, P. B., & Nelson, M. R. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.07.016 · Cited by 42 · see citing works

COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective

Marcelin, J. R., Pettifor, A. E., Janes, H., Brown, E. R., Kublin, J. G., & Stephenson, K. E. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac124 · Cited by 38 · see citing works

Frames that matter: Increasing the willingness to get the Covid-19 vaccines

Diament, S. M., Kaya, A., & Magenheim, E. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114562 · Cited by 37 · see citing works

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity

Pollett, S. D., Richard, S. A., Fries, A. C., Simons, M. P., Mende, K., Lalani, T., Lee, T., Chi, S., Mody, R. M., Madar, C., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab543 · Cited by 37 · see citing works

AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update

Sultan, S., Siddique, S. M., Singh, S., Altayar, O., Caliendo, A. M., Davitkov, P., Feuerstein, J. D., Kaul, V., Lim, J. K., Mustafa, R. A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.05.039 · Cited by 35 · see citing works

Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic

Wang, Y., Zheng, K., Gao, W., Lv, J., Yu, C., Wang, L., Wang, Z., Wang, B., Liao, C., & Li, L. (2022) · Medical Review · doi:10.1515/mr-2021-0034 · Cited by 35 · see citing works

Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial

Pajón, R., Paila, Y. D., Girard, B., Dixon, G., Kacena, K. A., Baden, L. R., Sahly, H. M. E., Essink, B. J., Mullane, K. M., Frank, I., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01679-5 · Cited by 33 · see citing works

Modelling direct and herd protection effects of vaccination against the SARS‐CoV‐2 Delta variant in Australia

McBryde, E. S., Meehan, M. T., Caldwell, J. M., Adekunle, A. I., Ogunlade, S. T., Kuddus, M. A., Ragonnet, R. R., Jayasundara, P., Trauer, J. M., & Cope, R. C. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51263 · Cited by 27 · see citing works

Infection Prevention during the Coronavirus Disease 2019 Pandemic

Reich, P. J., & Elward, A. M. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.12.002 · Cited by 27 · see citing works

Evolution of Responses to COVID-19 and Epidemiological Characteristics in South Korea

Jeon, J., Han, C. Y., Kim, T., & ‍Lee, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074056 · Cited by 23 · see citing works

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission

Swan, D. A., Goyal, A., Bracis, C., Moore, M., Krantz, E. M., Brown, E. R., Ojeda, E. F. C., Reeves, D. B., Gao, F., Gilbert, P. B., et al. (2021) · Viruses · doi:10.3390/v13101921 · Cited by 25 · see citing works

Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out

Mumtaz, G. R., El‐Jardali, F., Jabbour, M., Harb, A., Abu-Raddad, L. J., & Makhoul, M. (2021) · Vaccines · doi:10.3390/vaccines9070697 · Cited by 21 · see citing works

Low antispike antibody levels correlate with poor outcomes in COVID‐19 breakthrough hospitalizations

Sanghavi, D. K., Bhakta, S., Wadei, H. M., Bosch, W., Cowart, J. B., Carter, R. E., Shah, S. Z., Pollock, B. D., Neville, M. R., Oman, S. P., et al. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13471 · Cited by 21 · see citing works

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concernPreprint

Fiolet, T., Kherabi, Y., MacDonald, C. J., Ghosn, J., & Peiffer‐Smadja, N. (2021) · doi:10.31219/osf.io/z4x7t · Cited by 22 · see citing works

Mitigating SARS-CoV-2 Transmission in Hospitals: A Systematic Literature Review

Ng, C. Y. H., Lim, N.-A., Bao, L. X. Y., Quek, A. M. L., & Seet, R. C. S. (2022) · Public health reviews · doi:10.3389/phrs.2022.1604572 · Cited by 21 · see citing works

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens

Kanokudom, S., Chansaenroj, J., Suntronwong, N., Assawakosri, S., Yorsaeng, R., Nilyanimit, P., Aeemjinda, R., Khanarat, N., Vichaiwattana, P., Klinfueng, S., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.022 · Cited by 20 · see citing works

Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries

Clemens, J. D., Aziz, A. B., Tadesse, B. T., Kang, S. S. Y., Marks, F., & Kim, J. H. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101253 · Cited by 17 · see citing works

First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers

Coppeta, L., Balbi, O., Grattagliano, Z., Mina, G. G., Pietroiusti, A., Magrini, A., Bolcato, M., & Aurilio, M. T. (2021) · Vaccines · doi:10.3390/vaccines9060659 · Cited by 18 · see citing works

Effectiveness of Vaccination against SARS-CoV-2 Infection in the Pre-Delta Era: A Systematic Review and Meta-Analysis

Meggiolaro, A., Schepisi, M. S., Nikolaidis, G., Mipatrini, D., Siddu, A., & Rezza, G. (2022) · Vaccines · doi:10.3390/vaccines10020157 · Cited by 18 · see citing works

Prioritizing high-contact occupations raises effectiveness of vaccination campaigns

Nunner, H., van de Rijt, A., & Buskens, V. (2022) · Scientific Reports · doi:10.1038/s41598-021-04428-9 · Cited by 17 · see citing works

Breakthrough SARS-CoV-2 infections after COVID-19 immunization

Hirsh, J., Htay, T., Bhalla, S., Nguyen, V. T., & Cervantes, J. (2022) · Journal of Investigative Medicine · doi:10.1136/jim-2021-002131 · Cited by 17 · see citing works

COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021)

Hatcher, S. M., Endres‐Dighe, S. M., Angulo, F. J., Srivastava, A. K., Nguyen, J. L., Khan, F. L., Martin, C., Swerdlow, D. L., McLaughlin, J. M., Ubaka-Blackmoore, N., et al. (2022) · Vaccines · doi:10.3390/vaccines10030393 · Cited by 16 · see citing works

Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook

Storlie, C. B., Pollock, B. D., Rojas, R. L., Demuth, G., Johnson, P. W., Wilson, P. M., Heinzen, E. P., Liu, H., Carter, R. E., Habermann, E. B., et al. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.04.012 · Cited by 13 · see citing works

Association between vaccination and preventive routines on COVID-19-related mortality in nursing home facilities: a population-based systematic retrospective chart review

Nilsson, L. M., Andersson, C., Kastbom, L., & Sjödahl, R. I. (2022) · Primary Health Care Research & Development · doi:10.1017/s1463423622000640 · Cited by 12 · see citing works

Risk factors for intensive care unit admission and death from COVID-19 in fully vaccinated patients hospitalized for severe COVID-19, Brazil, 2021–2022

Houvèssou, G. M., Vargas, P. C. G., Jacques, N., & Leventhal, D. G. P. (2022) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2022.203 · Cited by 10 · see citing works

A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia

Alhandod, T. A., Rabbani, S. I., Almuqbil, M. S., Alshehri, S., Hussain, S. A., Alomar, N. F., Mir, M. A., & Asdaq, S. M. B. (2023) · Vaccines · doi:10.3390/vaccines11020281 · Cited by 10 · see citing works

Physical activities pre- and post-COVID-19 vaccination and its implementations: A narrative review

Al-Mhanna, S. B., Ghazali, W. S. W., Maqsood, A., Mohamed, M., Ahmed, N., Afolabi, H. A., Mutalub, Y. B., Heboyan, A. G., & Zafar, M. S. (2023) · SAGE Open Medicine · doi:10.1177/20503121231158981 · Cited by 10 · see citing works

Safe reopening of university campuses is possible with COVID-19 vaccination

Junge, M., Li, S., Samaranayake, S., & Zalesak, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270106 · Cited by 10 · see citing works

Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections

Macrae, K., Martínez-Cajas, J., Bessai, K., Abdulhamed, A., & Gong, Y. (2022) · Current Oncology · doi:10.3390/curroncol29100554 · Cited by 10 · see citing works

Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings

Panahi, Y., Einollahi, B., Beiraghdar, F., Darvishi, M., Fathi, S., Javanbakht, M., Shafiee, S., & Akhavan‐Sigari, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947602 · Cited by 10 · see citing works

Identification of the needs of individuals affected by COVID-19

Stanley, H. B., Pereda‐Loth, V., Mantel, M., Rouby, C., Daudé, C., Aguera, P., Fornoni, L., Hummel, T. R., Weise, S., Mignot, C., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00510-1 · Cited by 9 · see citing works

Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol

Pouquet, M., Decarreaux, D., Prévot-Monsacre, P., Hervé, C., Werner, A., Grosgogeat, B., Blanché, H., Rabiéga, P., Laupie, J., Kochert, F., et al. (2021) · Pathogens · doi:10.3390/pathogens10070911 · Cited by 9 · see citing works

The Impact of Childhood and Parental Vaccination on SARS-CoV-2 Infection Rates in Children

Yiğit, M., İnce, Y. E., Kalaycı, F., Santaflıoglu, B., Kurt, F., Parlakay, A. Ö., Mısırlıoğlu, E. D., & ŞENEL, E. (2022) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003625 · Cited by 9 · see citing works

Outbreak of SARS-CoV-2 Lineage 20I/501Y.V1 in a Nursing Home Underlines the Crucial Role of Vaccination in Both Residents and Staff

Orsi, A., Domnich, A., Pace, V. D., Ricucci, V., Caligiuri, P., Bottiglieri, L., Vagge, R., Cavalleri, M., Orlandini, F., Bruzzone, B. M., et al. (2021) · Vaccines · doi:10.3390/vaccines9060591 · Cited by 9 · see citing works

Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers

Trunfio, M., Verga, F., Ghisetti, V., Burdino, E., Emanuele, T., Bonora, S., Perri, G. D., & Calcagno, A. (2021) · Vaccines · doi:10.3390/vaccines9121377 · Cited by 9 · see citing works

Nucleocapsid-specific humoral responses improve the control of SARS-CoV-2Preprint

Dangi, T., Sanchez, S., Park, M.-C., Class, J., Richner, M., Richner, J. M., & Penaloza‐MacMaster, P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.09.483635 · Cited by 9 · see citing works

Quantitative Analysis of SARS-CoV-2 Antibody Status between Patients with Cancer and Healthy Individuals with Extended Vaccination Dosing Intervals in Canada

Robinson, A. G., Mazurek, A., Xu, M., & Gong, Y. (2021) · Current Oncology · doi:10.3390/curroncol29010006 · Cited by 8 · see citing works

Modeling Infectious Behaviors: The Need to Account for Behavioral Adaptation in COVID-19 Models.

Vardavas, R., de Lima, P. N., Davis, P. K., Parker, A. M., & Baker, L. (2021) · PubMed · Cited by 8 · see citing works

Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study

Kang, W., Yang, P., Dang, B., Zhang, W., Wang, W., Wang, W., Ma, C., Zhao, Y., 郝春秋, 郝春秋, et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.02.020 · Cited by 7 · see citing works

Vaccine Effects on Susceptibility and Symptomatology Can Change the Optimal Allocation of COVID-19 Vaccines: South Korea as an Example

Choi, W., & Shim, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132813 · Cited by 6 · see citing works

Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists

Patel, N., Bouchard, J. L., Oliver, M. B., Badowski, M. E., Carreno, J. J., & the Society of Infectious Diseases Pharmacists (2021) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2622 · Cited by 5 · see citing works

Quantitative Analysis of SARS-CoV-2 Serological Responses Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections

Macrae, K., Gong, C. Y., Sheth, P. M., Martínez-Cajas, J., & Gong, Y. (2022) · Vaccines · doi:10.3390/vaccines10101590 · Cited by 6 · see citing works

COVID-19 Vaccine Prioritisation in Japan and South KoreaPreprint

Chun, J. Y., Jeong, H., Beutels, P., Ohmagari, N., Kim, Y., & Tsuzuki, S. (2021) · medRxiv · doi:10.1101/2021.04.16.21255649 · Cited by 6 · see citing works

Early Real-World Data to Assess Benefits and Risks of COVID-19 Vaccines: A Systematic Review of Methods

Ribeiro, T. B., Roque, F., Ida, F., Plácido, A. I., Vu, M., Hernández‐Muñoz, J. J., & Herdeiro, M. T. (2022) · Vaccines · doi:10.3390/vaccines10111896 · Cited by 5 · see citing works

SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge – Denver, Colorado, and San Diego, California, January–April 2021

McCormick, D. W., Konkle, S. L., Magleby, R., Chakrabarti, A. K., Cherney, B., Lindell, K., Namageyo-Funa, A., Visser, S. N., Soto, R. A., Donnelly, M. A. P., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.066 · Cited by 5 · see citing works

mRNA vaccine effectiveness against asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection over seven months

Tande, A. J., Pollock, B. D., Shah, N. D., Binnicker, M. J., & Berbari, E. F. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.399 · Cited by 7 · see citing works

Novel deterministic epidemic model considering mass vaccination and lockdown against coronavirus disease 2019 spread in Israel: a numerical study

Utamura, M., Koizumi, M., & Kirikami, S. (2022) · Biology Methods and Protocols · doi:10.1093/biomethods/bpac023 · Cited by 5 · see citing works

Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak

Donadio, C., Rainone, A., Gouronnec, A., Belmin, J., & Lafuente‐Lafuente, C. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.04.004 · Cited by 5 · see citing works

Masking significantly reduces, but does not eliminate COVID-19 infection in a spatial agent-based simulation of a University dormitory floorPreprint

McPeck, R., & Mágori, K. (2021) · medRxiv · doi:10.1101/2021.09.13.21263458 · Cited by 5 · see citing works

Index cases first identified by nasal-swab rapid COVID-19 tests had more transmission to household contacts than cases identified by other test types

Ji, J., Winnett, A. V., Shelby, N., Reyes, J. A., Schlenker, N. W., Davich, H., Caldera, S., Tognazzini, C., Goh, Y.-Y., Feaster, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292389 · Cited by 5 · see citing works

Impact of Coronavirus Disease of 2019 Vaccine on Health and Physical Activities Among Physical Education Students in China

Laar, R. A., Zhang, Z., Menhas, R., Zhang, L., Zhu, S., Fan, X., Wang, W., & Li, S. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.889311 · Cited by 4 · see citing works

What we talk about when we talk about COVID-19 vaccination campaign impact: a narrative review

Filho, H. N. H., Peres, I. T., Maddalena, L. G., Baião, F., Ranzani, O., Hamacher, S., Maçaira, P., & Bozza, F. A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1126461 · Cited by 4 · see citing works

The Epidemiological, Clinical Features and Outcomes of Imported Chinese COVID-19 Patients Following Inactivated Vaccines Injection

Li, J., Jiang, N., Zeng, Q., Zhang, Y., He, X., Chu, Y., Jin, W., Liu, Y., Shi, W., Yang, M. S., et al. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s356460 · Cited by 4 · see citing works

Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS‐CoV‐2 in adults

Duan, R., Mao, Q., Xu, D., Qiu, Q., & Wang, P. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.670 · Cited by 4 · see citing works

A SARS CoV-2 nucleocapsid vaccine protects against distal viral disseminationPreprint

Class, J., Dangi, T., Richner, J. M., & Penaloza‐MacMaster, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.26.440920 · Cited by 4 · see citing works

Digital Health Passes in the Age of COVID-19: Are 'Vaccine Passports' Lawful and Ethical?Preprint

Gostin, L. O., Cohen, I. G., & Shaw, J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3824917 · Cited by 4 · see citing works

Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines

Pesce, M., Feikin, D. R., Higdon, M. M., O’Brien, K. L., Patel, M. K., Rearte, A., Vizzotti, C., Wilder‐Smith, A., & Parker, E. P. K. (2025) · Nature Communications · doi:10.1038/s41467-025-63950-w · Cited by 3 · see citing works

Countering vaccine hesitancy in the context of global health

Ayodele, J. O., Kekeisen-Chen, J. F., Lin, L. K., Said, A. H., Larson, H. J., & Mukumbang, F. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90945-7.00013-0 · Cited by 3 · see citing works

An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination

Chowdhury, P., Bhattacharya, S., Gogoi, B., Veeranna, R. P., & Kumar, S. (2022) · Vaccines · doi:10.3390/vaccines10101639 · Cited by 3 · see citing works

Universal admission laboratory screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) asymptomatic infection across a large health system

Cihlar, J. L., Harris, B. D., Wright, P. W., Humphries, R. M., Taylor, C. K., Cherry, B., & Talbot, T. R. (2022) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2022.301 · Cited by 3 · see citing works

Transmissibility of COVID-19 among Vaccinated Individuals: A Rapid Literature Review - Update #1Preprint

Egunsola, O., Mastikhina, L., Dowsett, L. E., Farkas, B., Hofmeister, M., Saxinger, L. M., & Clement, F. M. (2021) · medRxiv · doi:10.1101/2021.06.29.21255526 · Cited by 4 · see citing works

COVID-19 endgame: from pandemic to endemic? Vaccination, reopening and evolution in a well-vaccinated populationPreprint

Are, E. B., Song, Y., Stockdale, J. E., Tupper, P. F., & Colijn, C. (2021) · medRxiv · doi:10.1101/2021.12.18.21268002 · Cited by 3 · see citing works

Index Cases First Identified by Nasal-Swab Rapid COVID-19 Tests Had More Transmission to Household Contacts Than Cases Identified by Other Test TypesPreprint

Ji, J., Winnett, A. V., Shelby, N., Reyes, J. A., Schlenker, N. W., Davich, H., Caldera, S., Tognazzini, C., Goh, Y.-Y., Feaster, M., et al. (2023) · medRxiv · doi:10.1101/2023.03.09.23286855 · Cited by 3 · see citing works

A Macro-Level Association of Vaccination Rate with the Number of Confirmed COVID-19 Cases in the United States and Japan

Noda, H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127435 · Cited by 2 · see citing works

COVID-19 FAQs in Pediatric Cardiac Surgery: 2022 Perspective and Updates

Levy, E. R., Dearani, J. A., Blumenthal, J. A., Johnson, J. N., Overman, D. M., Stephens, E. H., & Chiotos, K. (2022) · World Journal for Pediatric and Congenital Heart Surgery · doi:10.1177/21501351221085966 · Cited by 2 · see citing works

PSLotto: A Privacy-Enhanced COVID Lottery System

Truex, S., & Alavidze, G. (2022) · IEEE International Conference on Cognitive Machine Intelligence (CogMI) · doi:10.1109/cogmi56440.2022.00019 · Cited by 2 · see citing works

Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 Polymerase Chain Reaction Screening: A Cost-Utility Analysis

Uno, S., Goto, R., Honda, K., Uchida, S., Uwamino, Y., Namkoong, H., Yoshifuji, A., Mikita, K., Takano, Y., Matsumoto, M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad463 · Cited by 2 · see citing works

Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual

Kernéis, S., Planas, D., Imbeaud, S., Staropoli, I., Puech, J., Robillard, N., Rodary, J., Bruel, T., Vieillard, T., Schwartz, O., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab369 · Cited by 2 · see citing works

SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies

Alidjinou, E. K., Gaillot, O., Guigon, A., Tinez, C., Lazrek, M., Bocket, L., Engelmann, I., & Hober, D. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115565 · Cited by 2 · see citing works

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax™) after homologous and heterologous two-dose regimensPreprint

Kanokudom, S., Chansaenroj, J., Suntronwong, N., Assawakosri, S., Yorsaeng, R., Nilyanimit, P., Aeemjinda, R., Khanarat, N., Vichaiwattana, P., Klinfueng, S., et al. (2022) · medRxiv · doi:10.1101/2022.09.07.22279684 · Cited by 2 · see citing works

COVID‐19: Epidemiology

Quiroz, P., Rutherford, G. W., & Dubé, M. P. (2022) · doi:10.1002/9781119789741.ch1 · Cited by 2 · see citing works

Vaccination, Compliance with Preventive Measures and Mental Health during COVID-19 among Adults in Bangladesh: Do Vaccination and Compliance with Preventive Measures Improve Mental Health?

Singha, B., Karmaker, S. C., Islam, M. M., Eljamal, K., & Saha, B. B. (2022) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2022.11.22 · Cited by 1 · see citing works

An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic

Hijano, D. R., Hoffman, J. M., Tang, L., Schultz‐Cherry, S., Thomas, P. G., Hakim, H., Webby, R. J., Hayden, R. T., Gaur, A. H., & St. Jude COVID-19 Employee Screening Program Team (2022) · PLoS ONE · doi:10.1371/journal.pone.0268237 · Cited by 4 · see citing works

BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection with SARS-CoV-2 Virus: A Nationwide Historical Cohort StudyPreprint

Heymann, A. D., Zacay, G., Shasha, D., Bareket, R., Kadim, I., Sikron, F. H., Tsamir, J., & Mossinson, D. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3796868 · Cited by 7 · see citing works

Characteristics of Asymptomatic COVID-19 In SARS-COV-2 Vaccine Trial Screening Participants

Farhanah, N., Pramudo, S. G., Hanifah, K., Nency, Y. M., Hapsari, R., Anantyo, D. T., Mulyono, M., Mahati, E., & Maharani, N. (2024) · The Open Public Health Journal · doi:10.2174/0118749445275380240123055732

Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination

North, C. M., Barczak, A. K., Goldstein, R. H., Healy, B. C., Finkelstein, D. M., Ding, D. D., Kim, A., Boucau, J., Shaw, B. M., Gilbert, R. F., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab643 · Cited by 28 · see citing works

Asymptomatic Pre-Operative COVID-19 Screening for Essential and Elective Surgeries: Early Results of Universal Screening at a Midwestern Academic Medical Center.

Hendrickson, N. R., Kesler, K. K., DeMik, D. E., Glass, N. A., Watson, M. K., Ford, B. A., Salinas, J. L., & Pugely, A. J. (2021) · Europe PMC (PubMed Central) · Cited by 4 · see citing works